BioSyent Inc.
BIOYF
$7.57
$0.20952.85%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.15M | 1.69M | 1.15M | 1.31M | 1.07M |
| Total Depreciation and Amortization | 337.00K | 80.70K | 84.50K | 80.60K | -32.00K |
| Total Amortization of Deferred Charges | 700.00 | 4.90K | 4.50K | 4.70K | 121.20K |
| Total Other Non-Cash Items | 212.80K | -58.80K | -60.00K | -163.70K | -282.30K |
| Change in Net Operating Assets | 335.90K | 3.12M | -2.29M | -524.70K | -377.10K |
| Cash from Operations | 1.87M | 4.84M | -1.10M | 708.80K | 496.10K |
| Capital Expenditure | -23.30K | -7.20K | -6.00K | -2.30K | -31.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.28M | -3.69M | 5.24M | 212.90K | -642.60K |
| Cash from Investing | 630.70K | -3.69M | 5.23M | 210.60K | -673.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -46.60K | -46.00K | -45.60K | -45.00K | -44.20K |
| Issuance of Common Stock | 162.20K | 50.20K | 38.00K | -- | 66.90K |
| Repurchase of Common Stock | -3.79M | -22.80K | -369.40K | -1.58M | -821.40K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -366.40K | -382.30K | -380.90K | -388.70K | -347.20K |
| Other Financing Activities | -14.00K | -14.60K | -15.00K | -15.60K | -16.40K |
| Cash from Financing | -3.00M | -406.70K | -667.40K | -1.60M | -946.30K |
| Foreign Exchange rate Adjustments | 22.30K | -18.90K | 200.00 | 100.00 | -111.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -477.20K | 720.10K | 3.46M | -683.30K | -1.24M |